Serbian tennis player Novak Djokovic has acquired 80% of Danish biotech QuantBioRes, which is developing a treatment for Covid-19, the company’s chief executive announced on Wednesday.
This announcement comes as the world number one, who refuses to be vaccinated, was excluded from the first Grand Slam tournament of the year, the Australian Open, and expelled from the country after having his visa canceled.
CEO Ivan Loncarevic said the investment was made in June 2020, but did not specify the amount.
QuantBioRes has about 11 researchers operating in Denmark, Australia and Slovenia, who were working on a treatment, not a vaccine, according to Loncarevic.
The company is developing a peptide, which prevents the coronavirus from infecting the human cell, and plans to start clinical trials in Britain this summer, he added.